Description
Desmopressin Acetate Tablets (0.1 mg / 0.2 mg)
Healthy Inc is a specialized global supplier and exporter of advanced endocrinology, urology, and targeted high-precision synthetic peptide therapeutics. We provide ultra-high-purity, kinetically stabilized Desmopressin Acetate Tablets (0.1 mg / 0.2 mg), manufactured in WHO–GMP certified, humidity-controlled, micro-dosing oral solid dosage facilities. This “Selective V2-Receptor Agonist” is a highly strategic, specialized export to pediatric hospitals, endocrinology clinics, urology networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, life-saving intervention for Central Diabetes Insipidus and severe Primary Nocturnal Enuresis.
Product Overview
This highly advanced formulation operates as a profound, centralized fluid regulator. It acts as a synthetic replacement for the human antidiuretic hormone (ADH), commanding the kidneys to stop producing vast, uncontrollable amounts of urine and physically forcing the body to retain essential water.
The “Synthetic Antidiuretic & V2 Agonist” Specialist:
- Mechanism 1 (The V2 Receptor Activation): Desmopressin mimics natural vasopressin but has been chemically modified to exclusively target V2 receptors located on the basolateral membrane of the collecting ducts in the kidneys. Binding to these receptors triggers the insertion of aquaporin-2 water channels into the apical membrane, physically opening the floodgates for water to be reabsorbed back into the bloodstream rather than being lost as urine.
- Mechanism 2 (The Cardiac-Safe Vasopressor Bypass): Natural human vasopressin acts on V1 receptors, which causes severe blood vessel constriction and massive blood pressure spikes. Desmopressin is structurally engineered to have virtually zero V1 receptor affinity. It delivers profound antidiuretic power without causing dangerous hypertension or cardiac stress.
- Mechanism 3 (The Oral Peptide Challenge): Peptides are normally destroyed by stomach acid. This formulation relies on an intensely precise excipient matrix that allows the microscopic 0.1 mg or 0.2 mg payload to survive just long enough to achieve its narrow ~0.1% systemic absorption. This tiny fraction is so incredibly potent that it provides 8 to 12 hours of total urinary control.
Product Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Desmopressin Acetate USP/Ph.Eur. (Equivalent to Desmopressin base) | 0.1 mg | The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. |
| Desmopressin Acetate USP/Ph.Eur. | 0.2 mg | The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. |
| Excipients | Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate | Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) |
*Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Endocrinology Distributors, and Hospital Procurement Boards.
| HS Code | 3004.39.00 (Medicaments containing hormones – Antidiuretics) |
| CAS Number | 1675-66-1 (Desmopressin Acetate) |
| Dosage Form | Uncoated Tablet (Immediate Gastric Release) |
| Packaging | High-Density Alu-Alu Blisters or HDPE Bottles with Desiccant (STRICTLY MANDATORY). Ensures the physical integrity of the fragile peptide and protects the formulation from degradation across Zone IVb tropical climates. |
| Storage | Store strictly below 25°C in a dry place. Protect heavily from Moisture and Heat. |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Oral Peptide Uniformity & Bioequivalence (CRITICAL COMPLIANCE): The therapeutic index for Desmopressin is fiercely unforgiving. If a generic manufacturer fails to perfectly blend the 0.1mg API, a patient may receive a tablet with 0.3mg, instantly triggering fatal water intoxication. Our endocrine suites utilize elite multi-stage geometric dry-blending and intensive HPLC batch-testing to guarantee 100% Content Uniformity. We ensure absolute, predictable fractional absorption, guaranteeing total safety for pediatric populations.
Therapeutic Indications (Human Use)
Indicated for the targeted management of severe fluid balance disorders:
- Central Diabetes Insipidus (CDI): The absolute first-line treatment for the massive, life-threatening polyuria (excessive urination) and polydipsia (excessive thirst) caused by a lack of natural pituitary ADH.
- Primary Nocturnal Enuresis: Management of severe bedwetting in children (typically aged 6 and older) when behavioral therapies have failed.
- Nocturia: Treatment of adults suffering from frequent nighttime awakenings to void urine.
Dosage & Administration
Recommended Dosage (Strictly as per Physician Guidelines):
- The Fluid Restriction Mandate (ABSOLUTE CRITICAL): When taking Desmopressin for bedwetting or nocturia, the patient MUST strictly limit fluid intake from 1 hour before administration until 8 hours after. Failure to restrict fluids will result in fatal water intoxication.
- Food Interaction: Must be taken on an empty stomach. Taking this peptide with food drastically decreases its already minuscule absorption rate, leading to total clinical failure.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- BLACK BOX WARNING (Severe Hyponatremia): Desmopressin can cause severe, life-threatening hyponatremia (dangerously low blood sodium levels) due to extreme water retention. This leads to cerebral edema, violent seizures, coma, and sudden death. Serum sodium levels must be monitored periodically.
- Renal Impairment Contraindication: Strictly contraindicated in patients with moderate to severe renal impairment (creatinine clearance below 50 mL/min).
- Polydipsia Contraindication: Contraindicated in patients with habitual or psychogenic polydipsia (compulsive water drinking), as they will rapidly induce fatal hyponatremia.
- Hyponatremia Risk Factors: Use with extreme caution in the elderly and in patients taking concurrent medications that cause hyponatremia (e.g., SSRIs, TCAs, NSAIDs, thiazide diuretics).
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Endocrinology/Pediatric Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Synthetic Peptides, Antidiuretic Hormones, and Extreme Microdose Formulations. Whether you are looking for a reliable Government Tender Supplier for pediatric hospitals in Africa or a B2B Pharma Marketplace partner for Southeast Asia, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.








Reviews
There are no reviews yet.